Commercially available enzyme-linked immunosorbent assays (ELISA) were used for determination of total GLP-1 (736 and 936) (ALPCO, Salem, NH), GLP-2 (133 and 333) (Merck Millipore, Burlington, MA) and DPP4 (R&D Systems, Minneapolis, MN) plasma concentrations and were carried out according to the manufacturers instructions
Patients who received SC semaglutide once a week for 68 weeks (20-week lead-in period + 48-week maintenance period) had an average weight loss of 17.4%
Common short-term side effects reported in studies include nausea, yawning, and changes in skin pigmentation
More research will be needed to verify some of the studys other conclusions
Each larva was placed in a separate well of a 48-well plate containing 1000 l of E3 buffer and kept at 28 C in a dark room to adapt for 30 min